Apodemus AB has sprung from research performed by one of the founders of the Company, Dr Niklasson, who had discovered a new virus group.

Initial research identified a strong association between infections caused by this virus group and several major disease.

Since 1999 Apodemus has been focused its resources to delineate the nature and pathways to infection, and on diagnostics and antiviral treatments for this virus group.